CARMEN SCHAUMBURG: Open Payments
NPI 1619208790 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$517 in 23 payments from 6 companies in 2025. Trend: 2023 $676 · 2024 $1,126 · 2025 $517
Food & beverage: $517
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $244 |
| Boston Scientific Corporation | 6 | $160 |
| Vericel Corporation | 1 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
| PFIZER INC. | 1 | $15 |
Products named: QULIPTA, Clinical Trial Product, UBRELVY, MACI, RELISTOR, WaveWriter Alpha Prime 16, JOURNAVX, General - Pain Management.
Industry payments across LA — which companies pay providers there.
